Expression of WT1 protein and correlation with cellular proliferation in glial tumors

被引：41

作者：

Hashiba, Tetsuo ^{[1
]}

Izumoto, Shuichi ^{[1
]}

Kagawa, Naoki ^{[1
]}

Suzuki, Tsuyoshi ^{[1
]}

Hashimoto, Naoya ^{[1
]}

Maruno, Motohiko ^{[1
]}

Yoshimine, Toshiki ^{[1
]}

机构：

[1] Osaka Univ, Dept Neurosurg, Grad Sch Med, Suita, Osaka 5650871, Japan

来源：

NEUROLOGIA MEDICO-CHIRURGICA | 2007年 / 47卷 / 04期

关键词：

immunotherapy; glioma; MIB-1; antibody; WT1; protein;

D O I：

10.2176/nmc.47.165

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

The expression of Wilms' tumor gene WT1 protein was investigated immunohistochemically in 73 glial tumors, including 60 astrocytic tumors, eight oligodendroglial tumors, and five ependymal tumors. WT1 protein was detected in 70 of the 73 glial tumors (95.9%) examined. Almost all glioblastomas, anaplastic astrocytomas, anaplastic ependymomas, and anaplastic oligodendrogliomas expressed high levels of WT1 protein. A significant (p < 0.001) correlation was found between WT1 protein expression and MIB-1 staining index. Histological examination found that WT1 protein was strongly expressed in the anaplastic portions and areas with perivascular proliferation and high cellularity, implying that WT1 gene might be important in glial tumor cell proliferation. WT1 gene is overexpressed in various types of solid tumors and WT1 protein is a target antigen for cancer immunotherapy. This study indicates that many malignant glial tumors are good candidates for cancer immunotherapy targeting WT1 protein and that WT1 protein expression could be used as a proliferation marker in glial tumors.

引用

页码：165 / 170

页数：6

共 27 条

[1] ISOLATION AND CHARACTERIZATION OF A ZINC FINGER POLYPEPTIDE GENE AT THE HUMAN CHROMOSOME-11 WILMS TUMOR LOCUS [J].

CALL, KM ;

GLASER, T ;

ITO, CY ;

BUCKLER, AJ ;

PELLETIER, J ;

HABER, DA ;

ROSE, EA ;

KRAL, A ;

YEGER, H ;

LEWIS, WH ;

JONES, C ;

HOUSMAN, DE .

CELL, 1990, 60 (03) :509-520

[2] Quantitative assessment of WT1 expression by real time quantitative PCR may be a useful tool for monitoring minimal residual disease in acute leukemia patients [J].

Cilloni, D ;

Gottardi, E ;

De Micheli, D ;

Serra, A ;

Volpe, G ;

Messa, F ;

Rege-Cambrin, G ;

Guerrasio, A ;

Divona, M ;

Lo Coco, F ;

Saglio, G .

LEUKEMIA, 2002, 16 (10) :2115-2121

[3] HOMOZYGOUS DELETION IN WILMS-TUMORS OF A ZINC-FINGER GENE IDENTIFIED BY CHROMOSOME JUMPING [J].

GESSLER, M ;

POUSTKA, A ;

CAVENEE, W ;

NEVE, RL ;

ORKIN, SH ;

BRUNS, GAP .

NATURE, 1990, 343 (6260) :774-778

[4]

Haber DA, 1996, MED PEDIATR ONCOL, V27, P453

[5] ALTERNATIVE SPLICING AND GENOMIC STRUCTURE OF THE WILMS-TUMOR GENE-WT1 [J].

HABER, DA ;

SOHN, RL ;

BUCKLER, AJ ;

PELLETIER, J ;

CALL, KM ;

HOUSMAN, DE .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (21) :9618-9622

[6]

HEWITT SM, 1995, CANCER RES, V55, P5386

[7] Long-term follow-up of minimal residual disease in leukemia patients by monitoring WT1 (Wilms tumor gene) expression levels [J].

Inoue, K ;

Ogawa, H ;

Yamagami, T ;

Soma, T ;

Tani, Y ;

Tatekawa, T ;

Oji, Y ;

Tamaki, H ;

Kyo, T ;

Dohy, H ;

Hiraoka, A ;

Masaoka, T ;

Kishimoto, T ;

Sugiyama, H .

BLOOD, 1996, 88 (06) :2267-2278

[8] WT1 AS A NEW PROGNOSTIC FACTOR AND A NEW MARKER FOR THE DETECTION OF MINIMAL RESIDUAL DISEASE IN ACUTE-LEUKEMIA [J].

INOUE, K ;

SUGIYAMA, H ;

OGAWA, H ;

NAKAGAWA, M ;

YAMAGAMI, T ;

MIWA, H ;

KITA, K ;

HIRAOKA, A ;

MASAOKA, T ;

NASU, K ;

KYO, T ;

DOHY, H ;

NAKAUCHI, H ;

ISHIDATE, T ;

AKIYAMA, T ;

KISHIMOTO, T .

BLOOD, 1994, 84 (09) :3071-3079

[9]

Kleihues P, 2000, WHO CLASSIFICATION T, P10

[10] Wilms tumor and the WT1 gene [J].

Lee, SB ;

Haber, DA .

EXPERIMENTAL CELL RESEARCH, 2001, 264 (01) :74-99

← 1 2 3 →